NUS
Nu Skin Enterprises Inc
4.60$
+1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 39.1% | 38.8% | 37.2% | 41.3% | 41.3% | 36.7% | 37.7% | 39.6% | 38.5% | 39.0% | 38.0% | 45.3% | |
| 13.0% | 14.2% | 12.2% | 14.1% | 14.4% | 12.7% | 14.6% | 18.3% | 17.7% | 17.0% | 14.4% | 16.9% | |
| 13.9% | 14.8% | 12.7% | 14.7% | 15.0% | 13.5% | 15.3% | 18.3% | 17.8% | 17.1% | 14.6% | 16.9% | |
| 4.3% | 3.2% | 3.8% | 4.5% | 4.3% | 3.5% | 4.1% | 4.1% | 3.4% | 2.8% | 3.3% | 4.4% | |
| 16.2% | 15.5% | 15.2% | 15.4% | 15.7% | 13.0% | 13.6% | 12.5% | 12.5% | 13.1% | 13.0% | 17.1% | |
| 28.7% | – | – | – | 31.3% | 30.8% | 33.0% | 31.3% | 32.0% | 32.1% | – | – | |
| 12.8% | 12.1% | 13.2% | 6.3% | 6.3% | 5.7% | 6.0% | 5.8% | 5.9% | 6.0% | 6.1% | 0.4% | |
| 6.1% | 5.3% | 5.9% | 5.6% | 5.4% | 5.1% | 3.4% | 3.2% | 3.1% | 3.0% | 2.9% | 3.4% | |
| 54.1% | 54.6% | 53.5% | 56.7% | 55.3% | 55.7% | 45.8% | 45.4% | 43.9% | 42.7% | 42.3% | 51.6% | |
| 24.2% | 18.2% | 17.8% | 19.5% | 21.4% | 20.2% | 18.7% | 19.7% | 17.9% | 18.8% | 18.7% | 22.9% | |
| 7.8% | 2.7% | 1.7% | 1.9% | 3.8% | 3.3% | 1.4% | 2.4% | 1.4% | 2.7% | 1.5% | 1.8% | |
| 2.7% | 2.4% | 1.9% | 2.3% | 2.1% | 2.4% | 2.4% | 2.0% | 2.0% | 1.9% | 2.1% | 3.4% | |
| 20.2% | 26.4% | 26.0% | 27.0% | 23.6% | 24.8% | 15.7% | 14.8% | 14.7% | 14.5% | 14.8% | 17.3% | |
| 45.9% | 45.4% | 46.5% | 43.3% | 44.7% | 44.3% | 54.2% | 54.6% | 56.1% | 57.3% | 57.7% | 48.4% | |
| 105.0% | 103.4% | 107.2% | 110.1% | 110.6% | 116.5% | 130.5% | 127.1% | 129.8% | 132.4% | 135.0% | 143.2% | |
| 2.8% | 2.7% | 2.8% | 3.1% | 3.1% | 3.4% | 3.6% | 3.4% | 3.5% | 3.6% | 3.6% | 4.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.